HEPATIC FIBROSIS

Clinical trials for HEPATIC FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new HEPATIC FIBROSIS trials appear

Sign up with your email to follow new studies for HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

First human test: does new liver drug affect the heart?

Knowledge-focused Not yet recruiting

This early-stage study aims to check if a single dose of an experimental drug called Hydronidone is safe for the heart. The drug is being developed to treat liver scarring (fibrosis). Researchers will give the drug to 48 healthy Chinese volunteers and closely monitor their heart …

Matched conditions: HEPATIC FIBROSIS

Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:37 UTC

HEPATIC FIBROSIS

Get alerted when new HEPATIC FIBROSIS trials appear

First human test: does new liver drug affect the heart?